Auto Amazon Links: No products found.
Researchers at the University of Cambridge have utilized artificial intelligence to create a fundamentally new type of vaccine designed to offer protection across a broad range of viruses, with the potential to prevent future pandemics. This development marks the first time that a vaccine’s main antigen has been entirely designed by AI and subsequently tested in human trials. The vaccine aims to provide immunity against all coronaviruses, including current Covid-19 variants and viruses harbored by animals that might spark future outbreaks.
Traditional vaccines are typically created based on existing viral strains, which poses challenges since many viruses rapidly mutate, rendering vaccines less effective over time. Covid-19 and seasonal flu vaccines, for example, require regular updates to keep up with these changes. Professor Jonathan Heeney from Cambridge explained the objective behind this new approach: “We’re always behind… what we’re trying to do is get ahead of the curve,” with the hope that these AI-designed vaccines could protect populations from future outbreaks and pandemics.
The process involved feeding genetic sequences of various coronaviruses, collected through viral surveillance programs, into an AI system. This system synthesized these inputs to design a “super-antigen” — a critical component that trains the immune system to recognize and respond to a wide family of viruses, regardless of mutations or cross-species transmission. According to Heeney, this represents a groundbreaking shift in pandemic preparedness. He stated, “This is a fundamental shift in how we prepare for pandemics,” emphasizing the technology’s unexpected potential and benefit to humanity.
Initial clinical trials conducted with 39 participants primarily tested the safety of the AI-designed vaccine. A subsequent trial with approximately 200 individuals will assess the immune response more thoroughly. While the immune reaction observed so far has been described as “modest,” experts are optimistic. Professor Saul Faust of the University of Southampton, who participated in the trials, remarked that the AI approach “definitely has potential” and is “really exciting.” Beyond coronavirus vaccines, the Cambridge team is also working on AI-generated vaccines targeting seasonal flu, H5N1 bird flu, and viral hemorrhagic fevers such as Ebola, which currently lacks a vaccine for the ongoing outbreak in the Democratic Republic of Congo. The broader scientific community views AI as a transformative tool in vaccine research, capable of accelerating development and saving lives
Read the full article from The BBC here: Read More
Auto Amazon Links: No products found.